These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9333591

  • 21. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
    Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F.
    G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
    [Abstract] [Full Text] [Related]

  • 22. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Electrophysiologic and antiarrhythmic properties of bepridil.
    Prystowsky EN.
    Am J Cardiol; 1985 Mar 15; 55(7):59C-62C. PubMed ID: 3872056
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 28. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A.
    Circulation; 1988 Oct 25; 78(4):863-9. PubMed ID: 3168194
    [Abstract] [Full Text] [Related]

  • 29. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY.
    Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280
    [Abstract] [Full Text] [Related]

  • 30. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI, Reiffel JA, Bigger JT, Squatrito A, Kidwell GA.
    Am Heart J; 1989 Mar 01; 117(3):562-8. PubMed ID: 2919535
    [Abstract] [Full Text] [Related]

  • 31. Initial onset of accessory pathway-mediated and atrioventricular node reentrant tachycardia after age 65: clinical features, electrophysiologic characteristics, and possible facilitating factors.
    Chen SA, Lee SH, Wu TJ, Chiang CE, Cheng CC, Tai CT, Chiou CW, Ueng KC, Wen ZC, Chang MS.
    J Am Geriatr Soc; 1995 Dec 01; 43(12):1370-7. PubMed ID: 7490388
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 01; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 33. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 01; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 34. Use of calcium channel entry blockers in the treatment of cardiac arrhythmias.
    Akhtar M, Tchou P, Jazayeri M.
    Circulation; 1989 Dec 01; 80(6 Suppl):IV31-9. PubMed ID: 2688983
    [Abstract] [Full Text] [Related]

  • 35. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
    Chiou CW, Chen SA, Kung MH, Chang MS, Prystowsky EN.
    Circulation; 2003 May 27; 107(20):2583-8. PubMed ID: 12743004
    [Abstract] [Full Text] [Related]

  • 36. [His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway].
    Finzi A, Potenza S, Guenzati G.
    G Ital Cardiol; 1990 Dec 27; 20(12):1161-7. PubMed ID: 2128068
    [Abstract] [Full Text] [Related]

  • 37. The mechanisms of spontaneous termination of reentrant supraventricular tachycardias.
    Chiale PA, Baranchuk A, González MD, Sánchez RA, Garro HA, Fernández PA, Avalos CQ, Enriquez A, Elizari MV.
    Int J Cardiol; 2015 Jul 15; 191():151-8. PubMed ID: 25965623
    [Abstract] [Full Text] [Related]

  • 38. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR.
    J Am Coll Cardiol; 1987 Jun 15; 9(6):1364-8. PubMed ID: 3584724
    [Abstract] [Full Text] [Related]

  • 39. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct 15; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 40. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G.
    Z Kardiol; 1992 Oct 15; 81 Suppl 4():139-43. PubMed ID: 1290290
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.